Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0368820070460030214
Journal of the Korean Neuropsychiatr Association
2007 Volume.46 No. 3 p.214 ~ p.222
Naturalistic, Retrospective Study on Clinical Experience of Ziprasidone in 3 University Hospitals
Lee Seung-Jae

Kang Do-Hyung
Hong Kyung-Sue
Joo Yeon-Ho
Kim Nam-Sick
kwon Jun-Soo
Abstract
Objectives: This naturalistic retrospective study investigated the effectiveness of ziprasidone measured by mean improvements of the Clinical Global Impression (CGI-I). Secondary objectives included prescribing patterns, tolerability and safety.

Methods: From May to July 2006, 98 psychiatric patients who have been taking ziprasidone for at least 2 weeks were selected. Their current clinical statuses were assessed by the interview and laboratory tests including electrocardiogram (ECG). Data on DSM-IV diagnoses, dosing, concomitant psychotropic medications, clinical changes, adverse effects, and laboratory findings were collected retrospectively.

Results: Ziprasidone was mostly prescribed for a switch from another antipsychotics for the treatment of schizophrenia. Two main reasons for a switch were unsatisfactory efficacy and poor tolerance, especially weight gain, of the preceding antipsychotic medication. Participants as a whole showed mean 2.7+/-1.0 of the CGI-Improvement. Significant weight reduction after switching to ziprasidone occurred, which was related to the clinical improvement. No significant increase of the QTc interval except one case was observed.

Conclusion: The present study confirmed previous tolerability and safety data of ziprasidone as well as the results of its effectiveness.
KEYWORD
Ziprasidone, Efficacy, Side effect, Schizophrenia, Other psychiatric disorder
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø